This article is a correction to:
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis
Burhan Ul Haq1
Hina Qayoom1
Shazia Sofi1
Nusrat Jan1Aisha Shabir1
Irshad Ahmad2
Fuzail Ahmad3Abdullah Almilaibary4
Manzoor A. Mir1*†- 1Department of Bioresources, School of Biological Sciences, University of Kashmir, Srinagar, India
- 2Department of Medical Rehabilitation Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia
- 3Respiratory Care Department, College of Applied Sciences, Almaarefa University, Diriya, Saudi Arabia
- 4Department of Family and Community Medicine, Faculty of Medicine, Al Baha University, Albaha, Saudi Arabia
A Corrigendum on
Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis
by Haq BU, Qayoom H, Sofi S, Jan N, Shabir A, Ahmad I, Ahmad F, Almilaibary A and Mir MA (2024). Front. Pharmacol. 14:1333447. doi: 10.3389/fphar.2023.1333447
In the published article, there was an error in Affiliation 3. Instead of “College of Applied Sciences, Almaarefa University, Diriya, Saudi Arabia,” it should be “Respiratory Care Department, College of Applied Sciences, Almaarefa University, Diriya, Saudi Arabia.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: breast cancer, mutation, p53 misfolding, aggregation, PhiKan-083, molecular docking
Citation: Haq BU, Qayoom H, Sofi S, Jan N, Shabir A, Ahmad I, Ahmad F, Almilaibary A and Mir MA (2024) Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis. Front. Pharmacol. 15:1494110. doi: 10.3389/fphar.2024.1494110
Received: 10 September 2024; Accepted: 12 September 2024;
Published: 30 September 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Haq, Qayoom, Sofi, Jan, Shabir, Ahmad, Ahmad, Almilaibary and Mir. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Manzoor A. Mir, ZHJtYW56b29yQGthc2htaXJ1bml2ZXJzaXR5LmFjLmlu
†ORCID: Manzoor A. Mir, https://orcid.org/0000-0003-3297-1402